A Aforeworn
Forewarned is forearmed.
Home › Niches › Cosmetics & Personal-Care (MoCRA) › Change
Low urgency

Medical Devices; Immunology and Microbiology Devices; Classification of the Spinal Muscular Atrophy Newborn Screening Test System

Detected July 6, 2026 · in Cosmetics & Personal-Care (MoCRA)

FDA classifies Spinal Muscular Atrophy newborn screening test system into class II with special controls. No direct impact on cosmetics or personal care under MoCRA.

Aforeworn detected this change in the Cosmetics & Personal-Care (MoCRA) space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. No cosmetics/personal care businesses affected should confirm how it applies to their specific situation before acting. There is a time constraint attached: N/A. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Cosmetics & Personal-Care (MoCRA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed. Regulated niches like Cosmetics & Personal-Care (MoCRA) move faster than most operators can track by hand, which is why Aforeworn watches the official sources for you and flags every material change the moment it appears.

What changed

FDA reclassified a medical device for newborn screening

Who it affects

No cosmetics/personal care businesses affected

What you must do

None for cosmetics/personal care

Deadline

N/A

Source: https://www.federalregister.gov/documents/2026/06/11/2026-11740/medical-devices-immunology-and-microbiology-devices-classification-of-the-spinal-muscular-atrophy

Never miss a change like this again

Aforeworn watches Cosmetics & Personal-Care (MoCRA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Cosmetics & Personal-Care (MoCRA)